Stock listing
Prescient Therapeutics Limited
Selected listing: PTX · ASX · AUD · AU
Prescient Therapeutics Limited (ASX:PTX), Health Technology. Latest release Sep 23, 2026: PTX Successfully Completes $6m Raise Via SPP and Placement.
- Ticker
- ASX:PTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
About Prescient Therapeutics Limited
The company focuses on developing innovative therapies for cancer treatment. Its research and development efforts aim to improve patient outcomes through targeted therapies.
Latest news from Prescient Therapeutics Limited
PTX Successfully Completes $6m Raise Via SPP and Placement
September 22, 2026
PTX-100 CTCL Phase 2a study reaches review milestone
September 2, 2026
Prescient Therapeutics Opens SPP to Raise $7m Today
August 25, 2026
Appendix 4E and 2026 Annual Report
August 20, 2026
June 2026 Quarterly Update and Appendix 4C
July 26, 2026
Research Prescient Therapeutics Limited
Prescient Therapeutics Limited company profile
View the public company page for Prescient Therapeutics Limited on 6ix.
Prescient Therapeutics Limited news
Read company news and market updates connected to Prescient Therapeutics Limited.
Prescient Therapeutics Limited investor events
Find investor webinars, events, and replay context for Prescient Therapeutics Limited.